Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42nd European Cystic Fibrosis Society Conference (ECFS)

Source :: GlobeNewswire. June 6, 2019
Publication Year :: 2019
Abstract: WALTHAM, Jun 06, 2019 (GLOBE NEWSWIRE via COMTEX) -- ELX-02 demonstrates dose-responsive pronounced increases in functional CFTR and read-through in organoids, human bronchial epithelial (HBE), and Ussing chamber systems ELX-02 [...]

Subjects :: Conferences and conventions -- Conferences, meetings and seminars
Cystic fibrosis -- Conferences, meetings and seminars
Associations -- Conferences, meetings and seminars
RNA -- Conferences, meetings and seminars
Messenger RNA
Fibrosis
Alleles
Clinical trials
Banking, finance and accounting industries
Business

Tools